Expert claims experimental therapy is helping the monarch stay strong
A royal expert has suggested that King Charles III may be benefiting from a discreet, cutting-edge cancer treatment following his diagnosis.
According to claims reported by Woman’s Day, commentator Tom Sykes said the monarch has been undergoing a combination of immunotherapy and an RNA-based cancer vaccine, administered through regular injections. The approach, still considered experimental, has drawn growing attention in medical research circles in recent years.
Sykes noted that, in the King’s case, the treatment appears to be delivering encouraging results. Speaking on a recent podcast, he said there is increasing optimism within royal circles that the monarch could continue his duties for many years.
While Buckingham Palace has not confirmed these details, sources close to the King reportedly describe the progress as promising.
The claims surfaced shortly after the King’s high-profile visit to the United States, where he maintained a packed schedule. The trip included formal speeches, state dinners, a stop in New York, and meetings with Donald Trump and Melania Trump.
Observers noted that the 77-year-old monarch handled the demanding itinerary with ease, showing little sign of slowing down despite his ongoing health battle.
